EXEL

Exelixis, Inc. News Headlines

$1.72
*  
0.02
1.18%
Get EXEL Alerts
*Delayed - data as of Sep. 18, 2014 11:02 ET  -  Find a broker to begin trading EXEL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    EXEL Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Biotech Portfolio Update: 2012 Summary And 2013 Outlook
12/24/2012 7:24:00 AM - Seeking Alpha

5 Medical Stock Losers From Last Week With High Short Ratios
12/22/2012 6:23:00 AM - Seeking Alpha

Exelixis Rebounds From 'Sell The News' Reaction
12/17/2012 10:58:00 AM - Seeking Alpha

Aveo Pharmaceuticals: A Hidden Gem Or A Hidden Disaster
12/10/2012 11:20:00 AM - Seeking Alpha

Biotech Weekly Recap: The Market Holds While Biotech Crumbles
12/9/2012 10:16:00 PM - Seeking Alpha

Acadia Pharmaceuticals: Making Big Waves
12/7/2012 1:12:00 PM - Seeking Alpha

VIX - Options Volatility Sonar: Wednesday Recap
12/5/2012 6:12:00 PM - Seeking Alpha

Exelixis' Promising Pipeline Of Drugs
12/4/2012 5:21:00 AM - Seeking Alpha

Biotech Weekly Recap: Loads Of Bullishness, 2 Giant Rallies, And Selling
12/2/2012 9:35:00 AM - Seeking Alpha

Prostate Cancer Market Takes Shape - Part 2: Treatments In Clinical Development
11/29/2012 11:53:00 AM - Seeking Alpha

Cramer's Lightning Round - American Tower Is One Of The Best Stories Out There (11/26/12)
11/27/2012 6:30:00 AM - Seeking Alpha

Exelixis Traders Brace For Upcoming FDA Decision
11/27/2012 3:57:00 AM - Seeking Alpha

Exelixis's Cabozantinib Should Receive FDA Approval, But Faces Long-Term Challenges
11/26/2012 3:00:00 AM - Seeking Alpha

Wednesday's Bio-Pharma Catalyst Trades And Watch List
11/21/2012 7:50:00 AM - Seeking Alpha

Cramer's Lightning Round - Qualcomm Is Finally Getting Respect (11/13/12)
11/14/2012 5:42:00 AM - Seeking Alpha

Biotech Catalyst Calendar - 4 Stocks To Watch In November
11/7/2012 8:59:00 AM - Seeking Alpha

3 November Catalysts For Biotech Traders
11/6/2012 5:05:00 AM - Seeking Alpha

Exelixis Stock Treads Water Ahead Of FDA Decision
10/26/2012 3:07:00 PM - Seeking Alpha

3 Companies With Promising New Cancer Treatments
10/23/2012 9:35:00 AM - Seeking Alpha

ArQule's Tivantinib Failure And Exelixis' Cabozantinib PDUFA: Is There A Correlation?
10/12/2012 9:10:00 AM - Seeking Alpha

Winners Of ESMO 2012
10/8/2012 6:07:00 PM - Seeking Alpha

Exelixis: First Partnered Program Enters Phase III
10/3/2012 8:25:00 AM - Seeking Alpha

As ArQule Investors Panic, Watch Exelixis Too
10/3/2012 8:19:00 AM - Seeking Alpha

3 Sub $10 Heavily Shorted High Volume Small Cap Biotechs Rated Buy With Momentum
9/20/2012 10:21:00 AM - Seeking Alpha

4 Biotech Stocks Ready to Explode
9/6/2012 1:30:00 PM - David Sterman